Role Of Animal Models In The Study Of Yellow Fever Disease And Vaccine
DOI:
https://doi.org/10.47611/jsrhs.v11i3.3599Keywords:
Model Organisms, Yellow Fever Virus, Mice, Hamsters, Non-human Primates, Yellow Fever VaccineAbstract
Yellow fever (YF) is a mosquito-borne disease caused by the neurovirulent and viscerotropic YF virus (YFV). Fevers, nausea, body aches, and fatigue commonly characterize the disease, with around 15% of infected people entering fatal phases. The mosquitos that typically carry YFV roam over Africa and South America, where approximately 1 billion people among 46 countries are at risk. A live-attenuated vaccine, strain 17D, was developed in the 1930s and used ever since. However, cases of adverse events presented after the administration of YF vaccines. Additionally, certain groups cannot take the YF vaccine due to its contraindications. Previous advancements in understanding the YFV and developing the vaccine are attributable to the use of animal models. Model organisms are also critical in implementing current modifications to the YF vaccine. This review will discuss these topics in greater detail with a heavy emphasis on the contribution of animal models to the study of YF, along with alternative methods to maximizing global immunity against YF.
Downloads
References or Bibliography
Centers for Disease Control and Prevention. (n.d.). Yellow fever. Centers for Disease Control and Prevention. Retrieved August 22, 2022, from https://wwwnc.cdc.gov/travel/diseases/yellow-fever#:~:text=Yellow%20fever%20is%20a%20disease,organ%20failure%2C%20and%20sometimes%20death
Centers for Disease Control and Prevention. (2020, December 18). Vaccine information. Centers for Disease Control and Prevention. Retrieved August 22, 2022, from https://www.cdc.gov/yellowfever/healthcareproviders/vaccine-info.html#:~:text=Yellow%20Fever%20Vaccine%20Information%20for%20Healthcare%20Providers&text=Sanofi%20Pasteur%2C%20the%20manufacturer%20of,YF%2DVax%20in%20June%202021.
Stamaril Yellow Fever vaccine. Welcome to Precision Vaccinations. (n.d.). Retrieved August 22, 2022, from https://www.precisionvaccinations.com/vaccines/stamaril-yellow-fever-vaccine
Package insert - YF-VAX - food and drug administration. (n.d.). Retrieved August 22, 2022, from https://www.fda.gov/media/76015/download
Frierson, J. G. (2010, June). The yellow fever vaccine: A history. The Yale journal of biology and medicine. PMID: 20589188
Retrieved August 22, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892770/
Davis, E. H., Thompson, J. K., Widen, S. G., & Barrett, A. D. T. (2021, July 16). Genome characterization of yellow fever virus wild-type strain Asibi, parent to live-attenuated 17D vaccine, from three different sources. Viruses. Retrieved August 22, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310116/. doi:10.3390/v13071383
Defining stage-specific activity of potent new inhibitors of ... (n.d.). Retrieved August 22, 2022, from https://journals.asm.org/doi/10.1128/mBio.00052-20. doi: https://doi.org/10.1128/mBio.01956-15
The Children's Hospital of Philadelphia. (2014, August 23). Yellow fever vaccine. Children's Hospital of Philadelphia. Retrieved August 22, 2022, from https://www.chop.edu/centers-programs/vaccine-education-center/vaccine-details/yellow-fever-vaccine#:~:text=The%20yellow%20fever%20vaccine%20is%20made%20by%20growing%20yellow%20fever,and%20over%20again%20weakened%20it
Centers for Disease Control and Prevention. (2021, April 21). Yellow fever vaccine. Centers for Disease Control and Prevention. Retrieved August 22, 2022, from https://www.cdc.gov/yellowfever/vaccine/index.html
Yellow fever vaccine information. Sanofi U.S. (n.d.). Retrieved August 22, 2022, from https://www.sanofi.us/en/products-and-resources/vaccines/yellow-fever-vaccine-information
World Health Organization. (n.d.). Yellow fever. World Health Organization. Retrieved August 22, 2022, from https://www.who.int/news-room/fact-sheets/detail/yellow-fever#:~:text=Vaccination%20is%20the%20most%20important,fever%20vaccine%20is%20not%20needed
Neale, T. (2010, February 13). Nursing mothers should avoid yellow fever vaccine. Medical News. Retrieved August 22, 2022, from https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/18466#:~:text=A%20single%20case%20report%20has,baby%20through%20her%20breast%20milk
Eliminate yellow fever epidemics (eye) - world health organization. (n.d.). Retrieved August 22, 2022, from https://apps.who.int/iris/bitstream/handle/10665/272408/9789241513661-eng.pdf
193–204 no 16 weekly epidemiological record relevé ... - who. (n.d.). Retrieved August 22, 2022, from https://apps.who.int/iris/bitstream/handle/10665/255040/WER9216.pdf?sequence=1
Shearer, F. M., Moyes, C. L., Pigott, D. M., Brady, O. J., Marinho, F., Deshpande, A., Longbottom, J., Browne, A. J., Kraemer, M. U. G., O'Reilly, K. M., Hombach, J., Yactayo, S., de Araújo, V. E. M., da Nóbrega, A. A., Mosser, J. F., Stanaway, J. D., Lim, S. S., Hay, S. I., Golding, N., & Reiner, R. C. (2017, November). Global yellow fever vaccination coverage from 1970 to 2016: An adjusted retrospective analysis. The Lancet. Infectious diseases. Retrieved August 22, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666204/. doi: 10.1016/S1473-3099(17)30419-X
Barrett, A. D. T., Dr. Alan D.T. Barrett on the current yellow fever epidemic and lessons about vaccine supply and global health. (08:12), Author AffiliationsFrom the Department of Pathology, Dr. Alan D.T. Barrett on the current yellow fever epidemic and lessons about vaccine supply and global health. (08:12), Derse, A. R., Davis, H. E. and C. S., Daval, C. J. R., C. T. Bramante and Others, J. P. Thornhill and Others, & S. S. Abdool Karim and N. Devnarain. (1970, August 20). Yellow fever in Angola and beyond - the problem of vaccine supply and demand: Nejm. New England Journal of Medicine. Retrieved August 22, 2022, from https://www.nejm.org/doi/10.1056/NEJMp1606997?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0www.ncbi.nlm.nih.gov. doi: 10.1056/NEJMp1606997
Ferguson, M., Shin, J., Knezevic, I., Minor, P., Barrett, A., & WHO Working Group. (2010, December 6). Who Working Group on technical specifications for manufacture and evaluation of yellow fever vaccines, Geneva, Switzerland, 13-14 May 2009. Vaccine. Retrieved August 22, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131007/. doi: 10.1016/j.vaccine.2010.10.070
EB;, H. (n.d.). Is it time for a new yellow fever vaccine? Vaccine. Retrieved August 22, 2022, from https://pubmed.ncbi.nlm.nih.gov/20971115/. doi: 10.1016/j.vaccine.2010.10.015
TP;, M. (n.d.). Review of the risks and benefits of yellow fever vaccination including some new analyses. Expert review of vaccines. Retrieved August 22, 2022, from https://pubmed.ncbi.nlm.nih.gov/22551029/. doi: 10.1586/erv.12.6
Lindsey NP;Rabe IB;Miller ER;Fischer M;Staples JE; (n.d.). Adverse event reports following Yellow Fever Vaccination, 2007-13. Journal of travel medicine. Retrieved August 22, 2022, from https://pubmed.ncbi.nlm.nih.gov/27378369/. doi: 10.1093/jtm/taw045
MK;, A. I. J. S. (n.d.). Questions regarding the safety and duration of immunity following live yellow fever vaccination. Expert review of vaccines. Retrieved August 22, 2022, from https://pubmed.ncbi.nlm.nih.gov/27267203/. doi: 10.1080/14760584.2016.1198259
Gershman MD;Staples JE;Bentsi-Enchill AD;Breugelmans JG;Brito GS;Camacho LA;Cottin P;Domingo C;Durbin A;Gascon J;Guenaneche F;Hayes EB;Jelenik Z;Khromava A;Martins Rde M;Wilson MM;Massy N;Nasidi A;Niedrig M;Sherwat A;Tsai T;Vilella A;Wilson ME;Kohl KS; ; (n.d.). Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of Immunization Safety Data. Vaccine. Retrieved August 22, 2022, from https://pubmed.ncbi.nlm.nih.gov/22561144/. doi: 10.1016/j.vaccine.2012.04.067
Tomashek, K. M., Challberg, M., Nayak, S. U., & Schiltz, H. F. (2019, November 8). Disease resurgence, production capability issues and safety concerns in the context of an aging population: Is there a need for a new yellow fever vaccine? Vaccines. Retrieved August 22, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963298/. doi: 10.3390/vaccines7040179
Meier KC;Gardner CL;Khoretonenko MV;Klimstra WB;Ryman KD; (n.d.). A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS pathogens. Retrieved August 22, 2022, from https://pubmed.ncbi.nlm.nih.gov/19816561/. doi: 10.1371/journal.ppat.1000614
JK;, E. A. K. P. (n.d.). Dynamic viral dissemination in mice infected with yellow fever virus strain 17D. Journal of virology. Retrieved August 22, 2022, from https://pubmed.ncbi.nlm.nih.gov/24027319/. doi: 10.1128/JVI.02149-13
Julander, J. G. (2016, April 16). Animal models of yellow fever and their application in Clinical Research. Current Opinion in Virology. Retrieved August 22, 2022, from https://www.sciencedirect.com/science/article/pii/S1879625716300426#sec0020. doi: https://doi.org/10.1016/j.coviro.2016.03.010
What is a mouse model? The Jackson Laboratory. (n.d.). Retrieved August 22, 2022, from https://www.jax.org/why-the-mouse/model#:~:text=Mice%20are%20the%20most%20commonly,any%20human%20disease%20or%20condition
Azamor, T., da Silva, A. M. V., Melgaço, J. G., Dos Santos, A. P., Xavier-Carvalho, C., Alvarado-Arnez, L. E., Batista-Silva, L. R., de Souza Matos, D. C., Bayma, C., Missailidis, S., Ano Bom, A. P. D., Moraes, M. O., & da Costa Neves, P. C. (2021, January 12). Activation of an effective immune response after yellow fever vaccination is associated with the genetic background and early response of IFN-γ and CLEC5A. Viruses. Retrieved August 22, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828179/. doi: 10.3390/v13010096
Moulin, J.-C., Silvano, J., Barban, V., Riou, P., & Allain, C. (2013, June 10). Yellow fever vaccine: Comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain. Biologicals. Retrieved August 22, 2022, from https://www.sciencedirect.com/science/article/pii/S1045105613000535. doi: https://doi.org/10.1016/j.biologicals.2013.04.005
Miao, J., Chard, L. S., Wang, Z., & Wang, Y. (1AD, January 1). Syrian hamster as an animal model for the study on infectious diseases. Frontiers. Retrieved August 22, 2022, from https://www.frontiersin.org/articles/10.3389/fimmu.2019.02329/full. doi :https://doi.org/10.3389/fimmu.2019.02329
Tesh, R. B., Guzman, H., da Rosa, A. P. A. T., Vasconcelos, P. F. C., Dias, L. B., Bunnell, J. E., Zhang, H., & Xiao, S.-Y. (2001, May 15). Experimental yellow fever virus infection in the Golden Hamster (mesocricetus auratus). I. Virologic, biochemical, and immunologic studies. OUP Academic. Retrieved August 22, 2022, from https://academic.oup.com/jid/article/183/10/1431/891721. doi: https://doi.org/10.1086/320199
Engelmann, F., Josset, L., Girke, T., Park, B., Barron, A., Dewane, J., Hammarlund, E., Lewis, A., Axthelm, M. K., Slifka, M. K., & Messaoudi, I. (n.d.). Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model. PLOS Neglected Tropical Diseases. Retrieved August 22, 2022, from https://journals.plos.org/plosntds/article?id=10.1371%2Fjournal.pntd.0003295 doi: https://doi.org/10.1371/journal.pntd.0003295
Leal SG;Romano AP;Monteiro RV;Melo CB;Vasconcelos PF;Castro MB; (n.d.). Frequency of histopathological changes in howler monkeys ( alouatta sp.) naturally infected with yellow fever virus in Brazil. Revista da Sociedade Brasileira de Medicina Tropical. Retrieved August 22, 2022, from https://pubmed.ncbi.nlm.nih.gov/27163561/. doi: 10.1590/0037-8682-0363-2015
Tomashek, K. M., Challberg, M., Nayak, S. U., & Schiltz, H. F. (2019, November 8). Disease resurgence, production capability issues and safety concerns in the context of an aging population: Is there a need for a new yellow fever vaccine? Vaccines. Retrieved August 22, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963298/. doi: 10.3390/vaccines7040179
Piras-Douce, F., Raynal, F., Raquin, A., Girerd-Chambaz, Y., Gautheron, S., Sanchez, M. E. N., Vangelisti, M., & Mantel, N. (2021, March 26). Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models. Vaccine. Retrieved August 22, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047865/. doi: 10.1016/j.vaccine.2021.02.033
Pereira RC;Silva AN;Souza MC;Silva MV;Neves PP;Silva AA;Matos DD;Herrera MA;Yamamura AM;Freire MS;Gaspar LP;Caride E; (n.d.). An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures. Vaccine. Retrieved August 22, 2022, from https://pubmed.ncbi.nlm.nih.gov/25862300/. doi: 10.1016/j.vaccine.2015.03.077
Monath TP;Lee CK;Julander JG;Brown A;Beasley DW;Watts DM;Hayman E;Guertin P;Makowiecki J;Crowell J;Levesque P;Bowick GC;Morin M;Fowler E;Trent DW; (n.d.). Inactivated yellow fever 17D vaccine: Development and nonclinical safety, Immunogenicity and protective activity. Vaccine. Retrieved August 22, 2022, from https://pubmed.ncbi.nlm.nih.gov/20347059/. doi: 10.1016/j.vaccine.2010.03.023
Roukens, A. H., Vossen, A. C., Bredenbeek, P. J., van Dissel, J. T., & Visser, L. G. (2008, April 23). Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: A randomized controlled non-inferiority trial. PloS one. Retrieved August 22, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2297511/.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Phyllis Liu; Hazal Gezmis
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
